Related Experiment Video
Updated: Aug 17, 2026

Home-Based EEG Hyperscanning for Infant-Caregiver Social Interactions
Published on: May 31, 2024
JAK the trigger
1Laboratoire d'hématopoïèse leucémique et cible thérapeutique, Université Victor Segalen Bordeaux 2, INSERM E0217, 33076 Bordeaux Cedex, France. francois-xavier.mahon@umr5540.u-bordeaux2.fr
Abstract:
A somatic mutation that leads to activation of the JAK2 tyrosine kinase has recently been identified as a recurrent genetic abnormality in several different myeloproliferative disorders. A translocation generating the constitutively activated fusion protein PCM1-JAK2 has also been recently found in atypical chronic myelogenous leukemia and acute leukemia. This recent spate of independent studies (one of which is published in this issue of Oncogene) establish abnormal JAK2 activation as the underlying defect in a significant number of cases of myeloproliferative disease, and JAK2 as an important new therapeutic target.
Related Concept Videos
Activation and Inactivation of G Proteins
Fixed Action Patterns
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...
Design Example: Automobile Ignition System
One can generate a large voltage using a car battery of 12 volts with the help of inductors. Inductors are known for opposing rapid...
Types Of Collisions - I
Impact Loading
In cases of elastic deformation,...

